Recent Updates
Recently added Catalysts
NUVL Positive Sentiment Score: 65/100

Nuvalent to Present at the 41st Annual J.P. Morgan Healthcare Conference Nuvalent, Inc., (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...

Wednesday, January 4, 2023 1 min read
Key Takeaway: Nuvalent, Inc. will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023. James Porter, Ph.D., the CEO, will discuss the company's targeted therapies for kinase targets in cancer. The presentation will highlight the company's focus on innovative cancer treatments and investor engagement. A live webcast will be available for those interested in the presentation and will be archived for 30 days.

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation at a major healthcare conference demonstrates company visibility.
  • Opportunity to showcase innovations and attract investor interest.
  • Leadership is actively engaging with the investment community.

Full Press Release Details

CAMBRIDGE, Mass. , Jan. 4, 2023 /PRNewswire/ -- Nuvalent, Inc. , (Nasdaq: NUVL ), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter , Ph.D., Chief Executive Officer, will present at the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 , at 7:30 a.m. PT in San Francisco .
A live webcast will be available in the Investors section of the company's website at www.nuvalent.com , and archived for 30 days following the presentation.
SOURCE Nuvalent, Inc.

21 %

Frequently Asked Questions

What is Nuvalent, Inc. focused on?

Nuvalent, Inc. specializes in developing targeted therapies for kinase targets in cancer.

When will James Porter present at the J.P. Morgan Conference?

James Porter will present on January 10, 2023, at 7:30 a.m. PT.

Where can I watch the live webcast of the presentation?

The live webcast will be available in the Investors section of Nuvalent's website.

How long will the webcast be available after the presentation?

The archived webcast will be accessible for 30 days following the presentation.

Tags: NUVL Viatris Investor Conferences Healthcare Nuvalent J.P. Morgan Healthcare Conference targeted therapies cancer biopharmaceutical
Last updated: Jan 4, 2023